Due to further growth of our company we have a number of new openings, including a Research Scientist to join our Immune Receptor Discovery team
If you are an enthusiastic and innovative team-player, who has a scientific background as below, and are looking to join a highly motivated team in a dynamic international environment, we would love to receive your application and get to know you further.
More about AgenTus Therapeutics....
Agentus Therapeutics is a biopharmaceutical company, and subsidiary of Agenus Inc, focusing on the discovery, development, and commercialization of breakthrough “living drugs” to advance cures for cancer patients. AgenTus employs naturally-derived and engineered receptors, specifically T Cell Receptors (TCRs) and Chimeric Antigen Receptors (CARs), designed to supercharge human immune effector cells to seek and destroy cancer. AgenTus will also aim to advance adoptive cell therapy formats which would enable off-the-shelf living drugs.